Drugmaker Mercks experimental COVID-19 pill is significantly less effective in slashing hospitalisations and deaths than previously reported, the company has said, following the release of a full analysis of trial results.
The United States-based firm said…
Merck’s COVID pill shows lower efficacy in updated study
Share this article
More News
Zoom Stock Analysis: Buy or Sell?
April 7, 2026
Americans Lost $11 Billion To Crypto Scams In 2025
April 7, 2026
